4-Chloro-1-(m-tolyl)-1H-pyrazolo[3,4-d]pyrimidine

Catalog No. :
ACZVPV425
CAS No. :
650628-11-8
Molecular Formula :
C12H9ClN4
Molecular Weight :
244.68

IUPAC Name:4-chloro-1-(m-tolyl)-1H-pyrazolo[3,4-d]pyrimidine

4-Chloro-1-(m-tolyl)-1H-pyrazolo[3,4-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$166.00Login to see priceInquiryInquiry
100mg95%$238.00Login to see priceInquiryInquiry
250mg95%$592.00Login to see priceInquiryInquiry
1g95%$750.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-1-(m-tolyl)-1H-pyrazolo[3,4-d]pyrimidine
IUPAC Name4-chloro-1-(m-tolyl)-1H-pyrazolo[3,4-d]pyrimidine
MDL No.MFCD03030405
Molecular FormulaC12H9ClN4
Molecular Weight244.68
SMILESCC1=CC(N2N=CC3=C(Cl)N=CN=C32)=CC=C1
InChI KeyDLHSWXBXKPTYSR-UHFFFAOYSA-N
Synonym1H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-1-(3-methylphenyl)-;4-Chloro-1-m-tolyl-1H-pyrazolo[3,4-d]pyrimidine
CAS No.650628-11-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZVPV425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOUQD946 route compound structure diagram
    ACOUQD946536-89-0 In Stock
  2. Plus
  3. ACITEF381 route compound structure diagram
    ACITEF3815305-40-8 In Stock
  4. Then
  5. ACZVPV425 route product structure diagram
    ACZVPV425650628-11-8
Inquiry

2. ACZVPV425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTYHX731 route compound structure diagram
    ACTYHX7315399-92-8 In Stock
  4. Then
  5. ACZVPV425 route product structure diagram
    ACZVPV425650628-11-8
Inquiry

Comments (0)